Viewing Study NCT03682705


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-02 @ 8:29 PM
Study NCT ID: NCT03682705
Status: COMPLETED
Last Update Posted: 2021-05-03
First Post: 2018-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-10-08
Start Date Type: ACTUAL
Primary Completion Date: 2020-03-26
Primary Completion Date Type: ACTUAL
Completion Date: 2020-03-26
Completion Date Type: ACTUAL
First Submit Date: 2018-09-21
First Submit QC Date: None
Study First Post Date: 2018-09-25
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-03-04
Results First Submit QC Date: None
Results First Post Date: 2021-05-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-04-06
Last Update Post Date: 2021-05-03
Last Update Post Date Type: ACTUAL